BTIG Raises GE HealthCare (GEHC) PT to $89 on Optimism for Q3 MedTech Results

Core Insights - GE HealthCare Technologies Inc. is identified as a promising stock to consider for investment, with a price target raised to $89 by BTIG analyst Ryan Zimmerman, reflecting optimism for upcoming Q3 results in the MedTech sector [1][2] - The MedTech sector is currently facing negative sentiment, but there is an expectation that quarterly results may exceed pessimistic forecasts due to delayed impacts of headline risks [1] - GE HealthCare has announced a collaboration with The Queen's Health Systems and Duke Health to develop AI-driven hospital operations software, enhancing its CareIntellect application suite [2][3] Company Overview - GE HealthCare develops, manufactures, and markets products and services for patient diagnosis, treatment, and monitoring across the US, Canada, and internationally [3]